TGTGInsighttelegram intelligenceLIVE / telegram public index
← Python Заметки

TGINSIGHT SIMILAR POSTS

Најди сличен содржај

Изворен канал @pythonotes · Post #357 · 14 дек.

На днях вышел Django 5. ▫️GeneratedField Поля, которые автоматически рассчитываются по экспрешену (Database generated model field). ▫️Фасетный фильтр для админки Показывает количество элементов для каждого фильтра. ▫️Async Добавлены асинхроные функции django.contrib.auth, ORM. Ряд декораторов теперь поддерживаются асинхронными вьюшками. ▫️ORM Новые возможносте полей, такие как поддержка словарей и функций в choices, дефолтные значения на стороне БД (Database-computed default values) с аргументом db_default и другие. ▫️Шаблоны Новые возможности шаблонов, позволяющие писать меньше кода в формах. #django

Hashtags

Резултати

Пронајдени 3 слични објави

Пребарај: #clinicalstage

当前筛选 #clinicalstage清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3534 · 20.12.2024 г., 09:31

$2.16M Fundraising by Umecrine Umecrine Cognition, a Swedish clinical-stage pharmaceutical firm, has raised $2.16 million to advance its innovative drug development targeting neurological disorders. The funding round took place on December 19, 2024. #UmecrineCognition#Pharmaceuticals#NeurologicalDisorders#Funding#Healthcare#ClinicalStage#Sweden

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 21.12.2024 г., 10:23

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 18.12.2024 г., 12:11

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform